Precision Bio-Interface

Plasma-Functionalized Hydrogels for Oncology

PlasmOnCo engineers advanced biomaterial matrices using cold atmospheric plasma, enabling targeted therapeutic delivery and microenvironment modulation to enhance cancer therapy.

Our Engineered Approach

Translational Biomaterial Process

01
02
03
04

Plasma Treatment

Molecular Bio-Functionalization

Targeted Localized Implantation

Controlled Kinetic Drug Release

Cold atmospheric plasma functionalization precisely implants reactive oxygen and nitrogen species (RONS) into hydrogel polymer networks.

Our process integrates specific biomolecules, programming the scaffold for targeted cellular interaction and therapeutic response.

Engineered scaffolds are designed for high-precision localized delivery, minimizing systemic exposure and maximizing therapeutic efficacy.

Customizable degradation rates ensure sustained and controlled release kinetics, perfectly matched to tumor histology and treatment protocols.

Validated Performance

Quantitative Scientific Metrics

100%

Filling of the resected tumor site for a Personalized medicine

~90%

Healthy cells viability to ensure selectivity

6-fold

Reduction of the chemotherapy dosis

— SCIENTIFIC EVIDENCE

Scientific Literature & Publications

Explore our body of peer-reviewed scientific articles and key presentations delivered at international oncology and cold plasma physics congresses validating PlasmOnCo's plasma-engineered hydrogel technology.

JOURNAL ARTICLES

Peer-Reviewed Manuscripts

Key publications from the PlasmaMED Lab Research Group at UPC towards cold atmospheric plasma interaction with the hydrogel scaffolds, localized RONS release dynamics, biological response and microenvironment modulation.

• M. Živanić, A. Espona-Noguera, H. Verswyvel, E. Smits, A. Bogaerts, A. Lin, C. Canal. Injectable Plasma-Treated Alginate Hydrogel for Oxidative Stress Delivery to Induce Immunogenic Cell Death in Osteosarcoma, Adv. Funct. Mater., 34, 2312005 (2024)

• J. Tornin, C. Labay, F. Tampieri, M.P. Ginebra, C. Canal. Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell cultures, Nature Protocols, 16, 2826 (2021)

• C. Labay, M. Roldán, F. Tampieri, A. Stancampiano, P. Escot Bocanegra, M.-P. Ginebra, C. Canal, Enhanced Generation of Reactive Species by Cold Plasma in Gelatin Solutions for Selective Cancer Cell Death, ACS Appl. Mater. Interfaces, 12, 42, 47256 (2020)

Advance Oncology Research

Collaborate with our team to explore the potential of plasma-functionalized hydrogels in your next breakthrough.